News and Announcements
The Greatest Mistake: Don’t Give Away Confidence When Raising Venture Capital | Learn How to Stay Confident and Secure Funding for Your Startup
- Published June 06, 2023 11:00PM UTC
- Publisher Wholesale Investor
- Categories Capital Raising Tips
When it comes to raising venture capital, it’s easy to fall into the trap of giving away your confidence. This is the greatest mistake a founder can make. Your success and failure in raising capital ultimately rests on your shoulders, and it’s up to you to reclaim your own confidence.
In this video, we provide insights and practical advice on how to maintain your confidence throughout the capital raising process. We cover topics such as how to approach investors, how to present your business, and how to handle rejection. We also share stories of successful founders who have maintained their confidence and gone on to raise significant capital.
Don’t let the fear of rejection or the pressure to perform erode your confidence. With the right mindset and approach, you can maintain your confidence and successfully raise the capital you need to grow your business. Watch this video to learn how.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
